The Valley Desk

NCT00660101 · Interventional trial

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Overall registry status Unknown

Phase 1 · Phase 2

Conditions Adenocarcinoma of the Ovary

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov